About Washington University School of Medicine, Psychiatry Dept.
Clinical Trials at Washington University School of Medicine, Psychiatry Dept.
During the past decade, Washington University School of Medicine, Psychiatry Dept. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Washington University School of Medicine, Psychiatry Dept."
#1 collaborator was "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "National Alliance for Research on Schizophrenia and Depression" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Washington University School of Medicine, Psychiatry Dept.
According to Clinical.Site data, the most researched conditions in "Washington University School of Medicine, Psychiatry Dept." are
"Schizophrenia" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Aggression" (1 trials), "Attention Deficit-Hyperactivity" (1 trials) and "Bipolar Disorder" (1 trials). Many other conditions were trialed in "Washington University School of Medicine, Psychiatry Dept." in a lesser frequency.
Clinical Trials Intervention Types at Washington University School of Medicine, Psychiatry Dept.
Most popular intervention types in "Washington University School of Medicine, Psychiatry Dept." are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "olanzapine" (2 trials), "risperidone" (2 trials), "Dexmedetomidine" (1 trials), "Ketamine" (1 trials) and "Risperidone, Olanzapine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Washington University School of Medicine, Psychiatry Dept.
The vast majority of trials in "Washington University School of Medicine, Psychiatry Dept." are
5 trials for "All" genders.
Clinical Trials Status at Washington University School of Medicine, Psychiatry Dept.
Currently, there are NaN active trials in "Washington University School of Medicine, Psychiatry Dept.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Washington University School of Medicine, Psychiatry Dept.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Washington University School of Medicine, Psychiatry Dept., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 3 trials that are defined as “Not Applicable".